Sign in or register to see full information and data.

Studies / CAVD 532


Study information

Grant Affiliation:Haynes: B cell Lineage Envelope Design from RV144 Antibodies
Strategy:Prophylactic neutralizing Ab
Study Type:Antibody Screening
Species:Non-Organism Study
Stage:Assays Completed
Study Start Date:2015-11-14
Study Made Public:2016-12-06


RV305 mAbs Differ in Strength and Breadth from RV144 mAbs


CAVD 532 is a monoclonal antibody screening study to evaluate V2-glycan binding in RV305 subjects.


ALVAC (vCP1521) AIDSVAX B/E Saline (non-specific) Placebo ALVAC Placebo AIDSVAX B/E

Integrated data

No integrated data is available for this study.

Non-integrated data

No non-integrated data is available for this study.